Clinical evaluation of disc battery ingestion in children

AliReza Mirshemirani1, Ahmad Khaleghnejad-Tabari1, Jaefar Kouranloo1

  • 1Pediatric Surgery Research Center, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Insights

Disc battery ingestion in children often resolves without complications. However, esophageal impaction requires immediate endoscopic removal to prevent serious issues like tracheo-esophageal fistula.

Area of Science:

  • Pediatric Gastroenterology
  • Emergency Medicine
  • Toxicology

Background:

  • Disc battery ingestion is a significant concern in pediatric healthcare.
  • Understanding the clinical course and outcomes is crucial for effective management.

Purpose of the Study:

  • To analyze the characteristics of disc battery ingestion in children.
  • To evaluate the management strategies and patient outcomes.
  • To identify risk factors for complications.

Main Methods:

  • Retrospective review of medical records for pediatric disc battery ingestions.
  • Data collection included patient demographics, symptoms, imaging, and treatment.
  • Analysis of endoscopic and surgical interventions and outcomes.

Main Results:

  • 22 pediatric cases of disc battery ingestion were identified.
  • Common symptoms included vomiting, cough, dysphagia, and dyspnea.
  • Esophageal impaction occurred in 3 cases, necessitating endoscopic removal; 4 patients required surgery for complications (tracheo-esophageal fistula, intestinal perforation).

Conclusions:

  • Most disc battery ingestions are managed successfully, with many batteries passing spontaneously.
  • Esophageal impaction demands urgent endoscopic intervention.
  • While generally benign, complications like tracheo-esophageal fistula and perforation highlight the need for vigilance.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
204
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
963